From Genomics to Gene Therapy: Induced Pluripotent Stem Cells Meet Genome Editing - PubMed (original) (raw)
Review
From Genomics to Gene Therapy: Induced Pluripotent Stem Cells Meet Genome Editing
Akitsu Hotta et al. Annu Rev Genet. 2015.
Abstract
The advent of induced pluripotent stem (iPS) cells has opened up numerous avenues of opportunity for cell therapy, including the initiation in September 2014 of the first human clinical trial to treat dry age-related macular degeneration. In parallel, advances in genome-editing technologies by site-specific nucleases have dramatically improved our ability to edit endogenous genomic sequences at targeted sites of interest. In fact, clinical trials have already begun to implement this technology to control HIV infection. Genome editing in iPS cells is a powerful tool and enables researchers to investigate the intricacies of the human genome in a dish. In the near future, the groundwork laid by such an approach may expand the possibilities of gene therapy for treating congenital disorders. In this review, we summarize the exciting progress being made in the utilization of genomic editing technologies in pluripotent stem cells and discuss remaining challenges toward gene therapy applications.
Keywords: CRISPR-Cas9; TALEN; genetic correction; pluripotent stem cells; programmable nuclease.
Similar articles
- CRISPR-Cas9: a promising tool for gene editing on induced pluripotent stem cells.
Kim EJ, Kang KH, Ju JH. Kim EJ, et al. Korean J Intern Med. 2017 Jan;32(1):42-61. doi: 10.3904/kjim.2016.198. Epub 2017 Jan 1. Korean J Intern Med. 2017. PMID: 28049282 Free PMC article. Review. - [CRISPR/Cas system for genome editing in pluripotent stem cells].
Vasil'eva EA, Melino D, Barlev NA. Vasil'eva EA, et al. Tsitologiia. 2015;57(1):19-30. Tsitologiia. 2015. PMID: 25872372 Review. Russian. - Site-Specific Genome Engineering in Human Pluripotent Stem Cells.
Merkert S, Martin U. Merkert S, et al. Int J Mol Sci. 2016 Jun 24;17(7):1000. doi: 10.3390/ijms17071000. Int J Mol Sci. 2016. PMID: 27347935 Free PMC article. Review. - Efficient Genome Editing in Induced Pluripotent Stem Cells with Engineered Nucleases In Vitro.
Termglinchan V, Seeger T, Chen C, Wu JC, Karakikes I. Termglinchan V, et al. Methods Mol Biol. 2017;1521:55-68. doi: 10.1007/978-1-4939-6588-5_4. Methods Mol Biol. 2017. PMID: 27910041 - Genetic correction using engineered nucleases for gene therapy applications.
Li HL, Nakano T, Hotta A. Li HL, et al. Dev Growth Differ. 2014 Jan;56(1):63-77. doi: 10.1111/dgd.12107. Epub 2013 Dec 11. Dev Growth Differ. 2014. PMID: 24329887 Review.
Cited by
- Genetically engineered human induced pluripotent stem cells for the production of brain-targeting extracellular vesicles.
Tang F, Dong T, Zhou C, Deng L, Liu HB, Wang W, Liu G, Ying M, Li PP. Tang F, et al. Stem Cell Res Ther. 2024 Oct 8;15(1):345. doi: 10.1186/s13287-024-03955-2. Stem Cell Res Ther. 2024. PMID: 39380039 Free PMC article. - Enhancing genome editing in hPSCs through dual inhibition of DNA damage response and repair pathways.
Park JC, Kim YJ, Hwang GH, Kang CY, Bae S, Cha HJ. Park JC, et al. Nat Commun. 2024 May 11;15(1):4002. doi: 10.1038/s41467-024-48111-9. Nat Commun. 2024. PMID: 38734692 Free PMC article. - Microphysiological Blood-Brain Barrier Systems for Disease Modeling and Drug Development.
Mulay AR, Hwang J, Kim DH. Mulay AR, et al. Adv Healthc Mater. 2024 Aug;13(21):e2303180. doi: 10.1002/adhm.202303180. Epub 2024 Mar 12. Adv Healthc Mater. 2024. PMID: 38430211 Review. - Generation of Human Isogenic Induced Pluripotent Stem Cell Lines with CRISPR Prime Editing.
Bonnycastle LL, Swift AJ, Mansell EC, Lee A, Winnicki E, Li ES, Robertson CC, Parsons VA, Huynh T, Krilow C, Mohlke KL, Erdos MR, Narisu N, Collins FS. Bonnycastle LL, et al. CRISPR J. 2024 Feb;7(1):53-67. doi: 10.1089/crispr.2023.0066. CRISPR J. 2024. PMID: 38353623 Free PMC article. - CRISPR-Cas Technology as a Revolutionary Genome Editing tool: Mechanisms and Biomedical Applications.
Ebrahimi S, Khosravi MA, Raz A, Karimipoor M, Parvizi P. Ebrahimi S, et al. Iran Biomed J. 2023 Sep 1;27(5):219-46. doi: 10.61186/ibj.27.5.219. Epub 2023 Jun 18. Iran Biomed J. 2023. PMID: 37873636 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical